- Home
- BLRX vs OCEA Comparison
BLRX vs OCEA Comparison
Compare BLRX & OCEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLRX
- OCEA
- Stock Information
- Founded
- BLRX 2003
- OCEA 2019
- Country
- BLRX Israel
- OCEA United States
- Employees
- BLRX N/A
- OCEA N/A
- Industry
- BLRX Biotechnology: Pharmaceutical Preparations
- OCEA Biotechnology: Pharmaceutical Preparations
- Sector
- BLRX Health Care
- OCEA Health Care
- Exchange
- BLRX Nasdaq
- OCEA Nasdaq
- Market Cap
- BLRX 36.0M
- OCEA 30.4M
- IPO Year
- BLRX 2011
- OCEA N/A
- Fundamental
- Price
- BLRX $0.20
- OCEA $0.58
- Analyst Decision
- BLRX Strong Buy
- OCEA
- Analyst Count
- BLRX 2
- OCEA 0
- Target Price
- BLRX $5.50
- OCEA N/A
- AVG Volume (30 Days)
- BLRX 2.2M
- OCEA 42.2K
- Earning Date
- BLRX 11-25-2024
- OCEA 12-24-2024
- Dividend Yield
- BLRX N/A
- OCEA N/A
- EPS Growth
- BLRX N/A
- OCEA N/A
- EPS
- BLRX N/A
- OCEA N/A
- Revenue
- BLRX $21,991,000.00
- OCEA N/A
- Revenue This Year
- BLRX N/A
- OCEA N/A
- Revenue Next Year
- BLRX N/A
- OCEA N/A
- P/E Ratio
- BLRX N/A
- OCEA N/A
- Revenue Growth
- BLRX N/A
- OCEA N/A
- 52 Week Low
- BLRX $0.19
- OCEA $0.52
- 52 Week High
- BLRX $1.70
- OCEA $7.79
- Technical
- Relative Strength Index (RSI)
- BLRX 24.20
- OCEA 29.53
- Support Level
- BLRX $0.23
- OCEA $0.58
- Resistance Level
- BLRX $0.56
- OCEA $0.70
- Average True Range (ATR)
- BLRX 0.03
- OCEA 0.05
- MACD
- BLRX -0.00
- OCEA -0.00
- Stochastic Oscillator
- BLRX 7.26
- OCEA 1.21
About BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
About OCEA Ocean Biomedical Inc.
Ocean Biomedical Inc is a biopharmaceutical company. It is dedicated towards partnering with inventor-scientists and research institutes to bridge the gap between basic research and clinical development, to get new medicines to the patients who need it most.